Alembic Pharmaceuticals Ltd reported a 12.1% year-on-year increase in consolidated net profit to ₹173.07 crore for the first quarter ended June.
The Indian generic drugmaker attributed the result to broad-based growth across its business segments.
Adani Energy Solutions recently posted a 124% surge in net profit, while ICICI Prudential Asset Management saw a 23% rise in earnings, signaling robust momentum in key Indian sectors.
The earnings release comes as several Indian listed companies report strong first-quarter results for fiscal 2027.
Adani Energy Solutions recently posted a 124% surge in net profit, while ICICI Prudential Asset Management saw a 23% rise in earnings, signaling robust momentum in key Indian sectors.
Alembic Pharma’s performance reflects continued demand for its pharmaceutical products.
The company’s ability to grow profits double-digits suggests operational efficiency and stable market conditions for its generic drug portfolio.